| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AIDS Pathogenesis Research Unit, Macfarlane Burnet Centre for Medical Research, Melbourne, Victoria, Australia
Correspondence: Prof. Suzanne M. Crowe, Macfarlane Burnet Centre for Medical Research, Yarra Bend Road, Fairfield, Victoria 3078, Australia. E-mail: tolli{at}burnet.edu.au
During highly active antiretroviral therapy (HAART), HIV-1 can still persist in circulating, resting CD4+ T lymphocytes, lymph node mononuclear cells, and seminal cells of patients despite sustained suppression of plasma viremia to undetectable levels. Sanctuary sites where antiretroviral drug penetration is not optimal may allow local HIV-1 infection of cells within and passing through these tissues. Factors such as imperfect drug adherence due to complicated drug regimens may also result in tissue compartments with suboptimal drug concentrations allowing viral replication. We have examined blood monocytes from HIV-1-infected subjects being effectively treated with HAART to determine virus carriage in these cells. Monocytes were purified from peripheral blood of patients with plasma HIV-1 RNA below 50 copies/mL and who had maintained levels of plasma RNA below detection for 3 months or more. Replication-competent virus could be recovered from the majority of monocyte populations by co-culture with CD8-depleted, PHA-activated, peripheral blood mononuclear cells. Sequencing of the reverse transcriptase and protease genes of the recovered viruses did not reveal resistance to both reverse transcriptase and protease inhibitors. Continued new infection of this transitory, circulating population of cells even during prolonged, effective HAART most likely reflects ongoing, low-level HIV-1 replication within cellular reservoirs and sanctuary sites in the body.
Key Words: reservoirs • macrophages • lymphocytes • persistence
This article has been cited by other articles:
|
|
 |
|
  I. Komuro, T. Sunazuka, K. S. Akagawa, Y. Yokota, A. Iwamoto, and S. Omura Erythromycin derivatives inhibit HIV-1 replication in macrophages through modulation of MAPK activity to induce small isoforms of C/EBP{beta} PNAS, August 26, 2008; 105(34): 12509 - 12514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Rossi, P. Franchetti, F. Pierige, L. Cappellacci, S. Serafini, E. Balestra, C.-F. Perno, M. Grifantini, R. Calio, and M. Magnani Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir J. Antimicrob. Chemother., April 1, 2007; 59(4): 666 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Cassol, M. Alfano, P. Biswas, and G. Poli Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence J. Leukoc. Biol., November 1, 2006; 80(5): 1018 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pinti, P. Biswas, L. Troiano, M. Nasi, R. Ferraresi, C. Mussini, J. Vecchiet, R. Esposito, R. Paganelli, and A. Cossarizza Different Sensitivity to Apoptosis in Cells of Monocytic or Lymphocytic Origin Chronically Infected with Human Immunodeficiency Virus Type-1 Experimental Biology and Medicine, December 1, 2003; 228(11): 1346 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Crowe, T. Zhu, and W. A. Muller The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection J. Leukoc. Biol., November 1, 2003; 74(5): 635 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Brooks, P. A. Arlen, L. Gao, C. M. R. Kitchen, and J. A. Zack Identification of T cell-signaling pathways that stimulate latent HIV in primary cells PNAS, October 28, 2003; 100(22): 12955 - 12960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Fraternale, A. Casabianca, L. Rossi, L. Chiarantini, G. F. Schiavano, A. T. Palamara, E. Garaci, and M. Magnani Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections J. Antimicrob. Chemother., October 1, 2003; 52(4): 551 - 554. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Komuro, Y. Yokota, S. Yasuda, A. Iwamoto, and K. S. Kagawa CSF-induced and HIV-1-mediated Distinct Regulation of Hck and C/EBP{beta} Represent a Heterogeneous Susceptibility of Monocyte-derived Macrophages to M-tropic HIV-1 Infection J. Exp. Med., August 4, 2003; 198(3): 443 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sonza, H. P. Mutimer, K. O'Brien, P. Ellery, J. L. Howard, J. H. Axelrod, N. J. Deacon, S. M. Crowe, and D. F. J. Purcell Selectively Reduced tat mRNA Heralds the Decline in Productive Human Immunodeficiency Virus Type 1 Infection in Monocyte-Derived Macrophages J. Virol., November 13, 2002; 76(24): 12611 - 12621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rice, R. Connor, S. Worgall, J. P. Moore, P. L. Leopold, R. J. Kaner, and R. G. Crystal Inhibition of HIV-1 Replication in Alveolar Macrophages by Adenovirus Gene Transfer Vectors Am. J. Respir. Cell Mol. Biol., August 1, 2002; 27(2): 214 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Davis, E. Read-Connole, K. Pearson, H. M. Fales, F. M. Newcomb, J. Moskovitz, and R. Yarchoan Oxidative Modifications of Kynostatin-272, a Potent Human Immunodeficiency Virus Type 1 Protease Inhibitor: Potential Mechanism for Altered Activity in Monocytes/Macrophages Antimicrob. Agents Chemother., February 1, 2002; 46(2): 402 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Gorry, G. Bristol, J. A. Zack, K. Ritola, R. Swanstrom, C. J. Birch, J. E. Bell, N. Bannert, K. Crawford, H. Wang, et al. Macrophage Tropism of Human Immunodeficiency Virus Type 1 Isolates from Brain and Lymphoid Tissues Predicts Neurotropism Independent of Coreceptor Specificity J. Virol., November 1, 2001; 75(21): 10073 - 10089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chougnet, C. Freitag, M. Schito, E. K. Thomas, A. Sher, and G. M. Shearer In Vivo CD40-CD154 (CD40 Ligand) Interaction Induces Integrated HIV Expression by APC in an HIV-1-Transgenic Mouse Model J. Immunol., March 1, 2001; 166(5): 3210 - 3217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Montaner, C.-F. Perno, and S. Crowe Macrophage infection by HIV-1: focus on viral reservoirs and pathogenesis J. Leukoc. Biol., September 1, 2000; 68(3): 301 - 302. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
